The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients

This study has been terminated.

First Received: November 2, 1999 Last Updated: June 23, 2005 History of Changes

Sponsor:	National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by:	National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:	NCT00001070

Purpose

This is a study to evaluate the tolerance and antiviral effect of oral vitamin C in HIV-infected.

Condition	Intervention
HIV Infections	Drug: Oral Vitamin C

Study Type:	Interventional
Study Design:	Treatment, Dose Comparison, Efficacy Study
Official Title:	A Dose Escalation Study to Evaluate Tolerance and Antiviral Effect of Oral Vitamin C in Two Groups of HIV-Infected Adults

Resource links provided by NLM:

MedlinePlus related topics: AIDS

Drug Information available for: Ascorbic acid

U.S. FDA Resources

Further study details as provided by National Institute of Allergy and Infectious Diseases (NIAID):

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Contacts and Locations

No Contacts or Locations Provided

More Information

No publications provided

Study ID Numbers:	DATRI 017
Study First Received:	November 2, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00001070 History of Changes
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

RNA Virus Infections
Sexually Transmitted Diseases, Viral
Antioxidants
Slow Virus Diseases
Molecular Mechanisms of Pharmacological Action
Immune System Diseases
Growth Substances
Physiological Effects of Drugs
Acquired Immunodeficiency Syndrome
Infection
Protective Agents

Pharmacologic Actions
Immunologic Deficiency Syndromes
Virus Diseases
HIV Infections
Vitamins
Sexually Transmitted Diseases
Lentivirus Infections
Micronutrients
Retroviridae Infections
Ascorbic Acid

ClinicalTrials.gov processed this record on November 09, 2009